Wellington Management Group’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,035,996
Closed -$10.7M 2073
2024
Q4
$10.7M Buy
1,035,996
+59,700
+6% +$577K ﹤0.01% 1177
2024
Q3
$9.27M Buy
976,296
+61,032
+7% +$527K ﹤0.01% 1196
2024
Q2
$7.8M Buy
915,264
+182,200
+25% +$1.67M ﹤0.01% 1219
2024
Q1
$6.78M Buy
733,064
+243,700
+50% +$2.14M ﹤0.01% 1255
2023
Q4
$4.75M Buy
489,364
+26,464
+6% +$247K ﹤0.01% 1323
2023
Q3
$4.15M Hold
462,900
﹤0.01% 1316
2023
Q2
$5.19M Buy
+462,900
New +$4.1M ﹤0.01% 1256

Other funds holding ENFN

Wellington Management Group's ENFN Position: Q1 2025 in Review

Wellington Management Group sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 1,035,996 shares — an estimated $10.7M sold.

Wellington Management Group first reported a position in ENFN in Q2 2023 and held it in 7 quarters. The position peaked at $10.7M in Q4 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • Wellington Management Group reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
  • Wellington Management Group sold 1,035,996 Enfusion, Inc. shares in Q1 2025, an estimated $10.7M.
  • Wellington Management Group first reported a position in Enfusion, Inc. in Q2 2023 and held it in 7 quarters.
  • Wellington Management Group's Enfusion, Inc. position peaked at $10.7M in Q4 2024.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on Wellington Management Group's 13F filing for Q1 2025, filed 13 May 2025.